Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva Receives FDA Approval for Migraine Autoinjector | Ctech
Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition | RAPS
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Teva Migraine Drug Wins FDA Nod, Bolstering Turnaround Plan - Bloomberg
Celltrion FDA warning causes headache for Teva's biologics ambition
FDA's Call on Migraine Drug Could Be Trouble for Teva | Barron's
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
Teva halts output at U.S. drug plant after FDA flags concerns | SaltWire
FDA Warning Letter Reveals Data and Sterility Issues at Teva Plant in Hungary | RAPS
The Teva Advantage
Jobs with Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals USA, Inc. Expands Voluntary Nationwide Recall of Losartan Potassium to 50 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply, Inc. | FDA
FDA Grants Approval For Teva's Generic Nasal Spray For Opioid Overdoses
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Teva Stops Production At US Plant After FDA Concerns: Report
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
